Trump, Pfizer and White House
Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...
PFE offers a 6.73% dividend yield and growth potential, driven by strategic acquisitions, R&D, and discounted valuations.
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
Pfizer said on Thursday it will end global development of its hemophilia gene therapy, Beqvez, citing soft demand from ...
Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...
Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Stock traders ...
According to multiple media reports on Thursday, Pfizer Inc. (NYSE:PFE) has terminated the global development and ...
All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...
HHS Secretary Robert F. Kennedy Jr. is preparing to remove committee members who advise the government on vaccine approvals ...
Pfizer is doubling down on its fight against cancer with a 60-second ad set to air during the first quarter of the game.
An archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. The claim by the user is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback